Research that is free to access for all investors. Companies commission these providers to write research about them.
Brokers who write research on their corporate clients and make it available through our main bundle offering.
Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.
Event in Progress:
Oxford BioMedica plc (OXB:LON) | 625 206.3 5.6% | Mkt Cap: 753.1m
Dr Mike Mitchell | Julie Simmonds
7 pages
Companies: GNS FDBK AMS SN/ EKF EAH ANCR FUM TSTL HIK CVSG SCLP COG HVO CTEC OXB DXRX NIOX SPI IHC AVCT HCM OHGR AREC MXCT ONT OPT
Companies: BNOWJASEE0RXCMHRE/SCELGENCMSARBBSIXHTONMURAGYCLIGINLGDRTRXSCLPCAMLCOSTIMEAVODNLOXBGETBKOOVVALYGENABZANSFTCFGTLYW7LPHPAVCTMCLBURDVLXPP
Companies: KOO MYE0 GNS FDBK AMS SN/ EKF ANCR FUM TSTL HIK CVSG SCLP COG HVO CTEC OXB DXRX NIOX SPI IHC AVCT HCM OHGR AREC OPT
Companies: CMHRE/SCEARBBSDMIQEMURAGYBLTGCNSLTRXSCLPCOSFULFDEVAVODNLOXBVALYGENABZANSFTCFG4MPHPPURPRTHMAVCTMCLPPHBURWBIDVLLUPGFMLM
Companies: MYE0 EKF HIK COG HVO OXB DXRX AREC
